Latest News

Financial Times - Oct 18

The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headings

- EY slims labor force for very first time in 14 years

- Sanofi joins competitors buying nuclear cancer treatment

- EU thinks about consisting of Elon Musk's service empire to determine potential X fine

- UK prepares to place 'buy now, pay later' lending institutions under FCA guidelines

- UK checks out plans for new rail line as option to axed HS2 northern leg

Summary

- Accounting company Ernst & & Young (EY) trimmed its international labor force in the past year as a downturn in need for its consulting services led the Big Four company to post its weakest profits development because 2010.

- French drugmaker Sanofi has actually struck a handle the hotly competitive radiopharmaceuticals sector, purchasing a $300. million stake in OranoMed, a subsidiary of French nuclear fuel. business Orano, that is establishing a brand-new cancer treatment.

- Elon Musk might face a large fine as the European. Commission take a look at including profits from the billionaire's. company empire to calculate a potential fine against social. media platform X.

- The UK government has actually launched a highly expected. assessment to bring buy now, pay later on lenders under the. analysis of the Financial Conduct Authority and the Consumer. Credit Act.

- The UK government is exploring proposals for a Birmingham. to Manchester railway line as an option to the axed. northern leg of HS2 high-speed rail network.

(source: Reuters)